Recent developments highlight product launches, strategic partnerships, and participation in investor conferences, reflecting ongoing efforts to expand market presence and product offerings.

• Functional Brands expanded international access for the P2i by Kirkman prenatal vitamin through iHerb, enhancing global distribution [N1].
• The company announced participation in the 38th Annual ROTH Conference, indicating engagement with investor and industry communities [N2].
• Functional Brands launched the Tru2u.health digital health platform delivering peptides, GLP-1 based care, telehealth support, and clean supplements [N3].
• Introduced Kirkman's Restorative Sleep Bundle designed for deep, refreshing sleep without grogginess [N4].
• Kirkman unveiled L Reuteri, a brain-protective probiotic with immune benefits [N5].
• DealFlow Discovery Conference announced Functional Brands among presenting companies, highlighting visibility in investment forums [N6].
• Introduced Kirkman Detox Aid Bundle for heavy metal and general detoxification support [N7].
• Launched Kirkman's Skin, Beauty & Anti-Aging Bundle, a science-backed approach to radiant, resilient skin [N8].

Functional Brands leverages its established Kirkman brand and extensive product portfolio to serve niche health segments with high-quality, rigorously tested supplements. The launch of the P2i by Kirkman certified prenatal vitamin aligns with emerging industry standards on safety and toxicity, potentially attracting health-conscious consumers and clinicians. The Tru2u.health platform extends the company's reach into digital health and telehealth services, supporting recurring revenue streams and consumer engagement. Strategic partnerships and modernization of manufacturing capabilities may enhance operational efficiency and market penetration. The company's international distribution network and direct-to-consumer channels provide diversified sales avenues.

The company faces significant risks including dependence on a single large customer (iHerb) for a substantial portion of revenue, which could materially impact financial results if lost. The Nasdaq deficiency letter regarding minimum bid price compliance poses a risk to continued listing status. Financial condition concerns are highlighted by auditor doubts about going concern status, recurring losses, and liquidity ratios below 1. Regulatory compliance in the dietary supplement industry and potential product liability claims present ongoing operational risks. The company’s limited operating history and need for additional financing may constrain growth and operational execution.

Functional Brands benefits from the long-established Kirkman brand with over 70 years of history and a loyal customer base, particularly in the autism and special dietary needs community. The company's commitment to high purity and quality standards, including rigorous testing and manufacturing in a certified facility, supports brand trust and repeat business. Its unique positioning with the P2i by Kirkman certified prenatal vitamin aligned with FIGO's low-toxicity standards provides a differentiated product in the prenatal supplement market. The integration of digital health services through Tru2u.health adds a recurring revenue dimension and broadens consumer engagement. These factors contribute to competitive strengths in a fragmented nutraceutical market.

• Customer Concentration Risk: Approximately 34% of revenue in 2025 was derived from a single customer, iHerb, with a purchase agreement in place. Loss of this customer could significantly impact revenues and financial condition [S1].
• Nasdaq Listing Compliance Risk: The company received a deficiency letter for not meeting the minimum $1.00 bid price requirement, with a compliance deadline of June 29, 2026. Failure to regain compliance could lead to delisting [S1].
• Financial Condition and Going Concern: Auditor expressed doubt about the company’s ability to continue as a going concern due to recurring losses, negative cash flows, and accumulated deficit. Liquidity ratios indicate current liabilities exceed current assets [S1].
• Regulatory and Product Liability Risks: The dietary supplement industry is subject to FDA and FTC regulations. The company faces risks of product liability claims and potential uninsured losses, which could adversely affect operations and reputation [S1].
• Dependence on Supply Chain and Manufacturing: Disruptions in supply chain or manufacturing capacity could materially impact the company’s ability to deliver products timely and cost-effectively [S1].